1,4-disubstituted piperazine derivatives useful as uro-selective alpha1-adrenoceptor blockers

Details for Australian Patent Application No. 2002222315 (hide)

Owner Ranbaxy Laboratories Limited

Inventors Gupta, Jang Bahadur; Sinha, Neelima; Anand, Nitya; Hegde, Laxminarayan G.; Chugh, Anita; Jain, Sanjay

Agent Callinan

Pub. Number AU-B-2002222315

PCT Pub. Number WO02/44151

Priority 1097/DEL/2000 30.11.00 IN

Filing date 29 November 2001

Wipo publication date 11 June 2002

Acceptance publication date 21 June 2007

International Classifications

A61K 31/497 (2006.01)

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 209/48 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

21 June 2007 Application Accepted

  Published as AU-B-2002222315

18 October 2007 Standard Patent Sealed

26 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002222316

2002222314